<DOC>
	<DOC>NCT00660192</DOC>
	<brief_summary>The hypothesis of this study is that injection of botulinum toxin A into the muscles around the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and frequency of migraine headaches by 50%.</brief_summary>
	<brief_title>Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches</brief_title>
	<detailed_description>Contact PI for study details</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Adults 18 and older Migraine for more than three months, that fail to respond to two or more major antimigraine drug, meeting criteria of chronic migraine Age below 18 Pregnant or may become pregnant Disease of neuromuscular junction or drugs that affect NM junction Allergy to Botox Previous use of Botox for migraine by similar methodology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Migraine, refractory migraine, Pain, Botulinum Toxin , Botox</keyword>
</DOC>